ACRX Shares Outstanding History



Below is a table of the ACRX shares outstanding history going back to 2/4/2011:

Date ACRX Shares Outstanding
2/4/2011806733
3/29/2011968588
5/1/2011968588
8/1/2011970983
11/1/2011977650
1/31/2012978389
5/1/2012984608
7/1/20121.13M
10/15/20121.13M
1/31/20131.85M
4/25/20131.86M
7/30/20132.11M
10/15/20132.15M
2/25/20142.16M
4/17/20142.17M
7/21/20142.17M
10/24/20142.19M
2/25/20152.19M
4/22/20152.22M
7/21/20152.22M
10/21/20152.22M
2/24/20162.26M
4/21/20162.27M
7/21/20162.27M
10/21/20162.27M
2/23/20172.27M
4/27/20172.27M
7/26/20172.27M
10/25/20172.52M
2/26/20182.54M
5/7/20182.57M
7/26/20183.03M
10/30/20183.10M
2/25/20193.94M
4/18/20193.94M
5/2/20193.95M
7/24/20193.97M
8/2/20196.33M
10/28/20193.98M
3/5/20204.02M
4/13/20204.02M
5/7/20204.04M
8/3/20204.52M
10/28/20204.52M
3/9/20215.95M
5/3/20215.96M
8/11/20215.96M
11/10/20215.97M
3/7/20227.35M
5/10/20227.36M
11/10/20227.45M
3/20/202310.92M
8/7/202316.34M
11/3/202316.95M

Also see: ACRX Market Cap History
ACRX YTD Return
ACRX Historical Shares Outstanding:
+26.98% CAGR
ACRX Historical Shares Outstanding: +26.98% CAGR

Mouse over chart for data details
2/4/2011 ...11/3/2023
AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. Co.'s nafamostat product candidates include Niyad™, which is being developed as a regional anticoagulant for injection into the extracorporeal circuit; and LTX-608, which is Co.'s proprietary nafamostat formulation for direct IV infusion. Co.'s pre-filled syringe product candidates include Fedsyra™, which is an ephedrine pre-filled syringe; and the phenylephrine pre-filled syringe. We show 54 historical shares outstanding datapoints in our coverage of ACRX's shares outstanding history.

Understanding the changing numbers of ACRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACRX by allowing them to research ACRX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ACRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AcelRx Pharmaceuticals (ACRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ACST Shares Outstanding History
ACXP Shares Outstanding History
ADGI Shares Outstanding History
ADIL Shares Outstanding History
ADMA Shares Outstanding History
ADMP Shares Outstanding History
ADMS Shares Outstanding History
ADPT Shares Outstanding History
ADRO Shares Outstanding History
ADTX Shares Outstanding History
More Healthcare companies »

 

ACRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.